Is It Too Late To Invest In Whitbread plc, Ashtead Group plc, Consort Medical plc & Servoca Plc?

Whitbread plc (LON:WTB), Ashtead Group plc (LON:AHT), Consort Medical plc (LON:CSRT) and Servoca (LON:SVCA) are under the spotlight.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Here’s my quick take on four companies that reported their trading updates today. 

Whitbread: A Long-Term Play

Its interim management statement for the 13 weeks to 28 May showed why Whitbread (LSE: WTB) deserves plenty of attention: like-for-like sales growth at Premier Inn and Costa stands at 6.3% and 5%, respectively. 

Moreover, Whitbread plans to open around “5,500 new Premier Inn UK rooms and around 250 net new Costa stores worldwide“. 

Our committed UK pipeline has grown to 13,339 rooms and construction is underway on 42 new hotel sites as well as 19 hotel extensions,” it added.

The stock’s performance is broadly in line with that of the FTSE 100 at the time of writing, and that’s because investors want even more growth from this stock market darling — but at 21x forward earnings, WTB remains a buy, in my view. If it keeps up with this growth rate, revenues will have grown at a compound annual growth rate of 14.4% between 2013 and 2016 — and there’s more to come. 

WTB remains a long-term value play. 

Ashtead Group: Focus Is On Cash Flows 

Ashtead (LSE: AHT) is doing well both in the US and in Britain, its annual results showed today. So, why is AHT down 2.6% today at the time of writing, and 4% year to date? 

It looks like analysts are less upbeat about its growth prospects at 1,100 a share, where it currently trades. Barclays, for instance, decided to cut its price target to 1,375p today, which implies a rather high forward price-to-earnings ratio of about 20x. 

Certainly, the yield it offers isn’t particularly appealing, but its growth rate is outstanding. Fundamentals are solid, while net leverage is under control. If anything, additional cash returns to shareholders should be ruled out at least until its core cash flow profile improves. 

That said, I’d hold onto AHT if I were invested. 

Keep An Eye On Consort Medical (£455m market cap) & Servoca (£28m market cap)

These are two smaller business that investors should keep on the radar, in my opinion. 

Consort Medical‘s (LSE: CSRT) results were a mixed bag, but there’s a lot to like in the way management is pushing ahead with an aggressive capital allocation strategy that may eventually allow its stock to beat its previous records over the next 24 months.

Unchanged final dividend of 11.68p per share; total full year dividend unchanged at 18.11p,” was one element I did not like in its release, but was in line with expectations. A closing net debt position of £99.2m (FY2014: net cash £25.8m), which implies net leverage of 2.3x (“comfortably within the banking facility covenant”) signals efficiency, at least financially, however. 

On average, its shares have risen at a 40% clip over the last five years: they do not trade in bargain territory, based on cash flow multiples, but they are not expensive, either. 

Elsewhere, Servoca (LSE: SVCA) is up 30% this year. Volumes are thin, which heightens the risk of the investment, of course. I am fairly relaxed about that, and I’d focus on the unaudited interim results (for the six months ended 31 March 2015) of this specialist outsourcing and recruitment solutions provider, which showed today a strong rate of growth for revenues and earnings as well as declining net debt. All good here. 

This is a business at a growth stage, operating in a very promising sector and with a clear focus (healthcare, education) on operations. Its lofty valuation could drop fast if management continues to deliver, drawing the attention of bigger recruitment agencies in the UK, where consolidation is likely to speed up sooner rather than later. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »